Two pediatric neurosurgeons join Department of Neurosurgery, bringing expertise to grow clinical and research programs
Pediatric neurosurgeons in the Department of Neurological Surgery at the Indiana University School of Medicine bring a unique set of skills each day as they treat children of all ages at Riley Children’s Health and lead clinical research in groundbreaking neurosurgery techniques. Two neurosurgeons who recently joined department faculty in August 2024 — Jason Chu, MD, MSc and Thomas Larrew, MD — have expanded the already robust pediatric specialty.
Two functional neurosurgeons join the Department of Neurosurgery
Jason Schwalb, MD, Betsey Barton Professor of Neurological Surgery, and David Purger, MD, PhD, assistant professor of neurological surgery, joined department faculty in September 2024.
Neuroimmunology and neurodegeneration researcher joins growing team of Alzheimer’s disease researchers at the IU School of Medicine
Malú Tansey, PhD and her team of researchers like to think “outside the brain.” Her lab investigates the role of inflammation and immune system responses
IU-led consortium focused on developing the next generation of Alzheimer’s disease animal models featured in Alzheimer’s & Dementia journal
Anationalresource for Alzheimer’s disease animal models and preclinical testing of therapeutics, led in part by Indiana University School of Medicine researchers, is the focus of a special issue
$3.5 million grant to fund study of connection between Alzheimer’s disease, traumatic brain injury
Researchers from the Indiana University School of Medicine and the University of California, Riverside are investigating how traumatic brain injuries and genetic risk factors can
Early career researcher leading international cohort of scientists in Alzheimer’s Association ambassador program
Paige Logan, a laboratory research specialist and lab manager at the Indiana University School of Medicine was selected as the lead ambassador for the Alzheimer's Association's
Alzheimer's disease basic science finding leads to clinical trial
A novel therapeutic target to treat Alzheimer’s disease identified in 2022 by Indiana University School of Medicine researchers will now be translated to a clinical
IU-led team to develop AI-driven prediction model for sinus surgery patients
Indiana University School of Medicine researcher Vijay Ramakrishnan, MD, is leading a multi-institutional five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID)